AbCellera Bio - ABCL Real Price to Acquire Entire Company
AbCellera Biologics (ABCL) is developing an AI system for antibody discovery utilizing a proprietary microfluidic cell analysis method. Operations are based in North America and rely on collaborations with global pharmaceutical behemoths. This chart reflecting value dynamics shows an Enterprise Value of 3990.53. Future high margins are secured through royalty rights and deep technological expertise.
AbCellera Corp (ABCL) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:abcellera.com (ABCL)
Asset managers require an objective metric to determine the fair value of a business. This indicator sums market capitalization and net debt, reflecting the actual cost of a full buyout of the issuer. By analyzing the total enterprise value, an investor can track the company's valuation dynamics without reporting distortions. For AbCellera Biologics (ABCL), this figure reflects the market rate for the potential of its AI platform for antibody discovery. Enterprise value here correlates with the efficiency of the R&D pipeline and the pace of technological updates.
Competitor analysis for AbCellera Biologics
Total Company Value argenx N.V. ARGX|BNTX: Enterprise Value|ABVX: Real Price to Acquire Entire Company|ADMA Biologics (ADMA) - Total Company Value|PTGX (protagonist-inc.com) - Total Company Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|TRML (Tourmaline Bio, Inc.) - Enterprise Value|Enterprise Value precigen.com (PGEN)|Pharming Group (PHAR) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Nektar Therapeutics Inc (NKTR)|Enterprise Value UPB|Zenas Corp - Company Buyout Price|IMNM: Total Company Value|GOSS: Real Price to Acquire Entire Company|KALV (KalVista Pharmaceuticals, Inc.) - Total Company Value|Real Price to Acquire Entire Company Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Real Price to Acquire Entire Company|Enterprise Value SVRA|Total Company Value Rigel Pharmaceuticals RIGL|Business Value anaptysbio.com (ANAB)|ATXS: Enterprise Value|Total Enterprise Value enGene Holdings Inc ENGN|RAPT Therapeutics - Enterprise Value|JBIO - Enterprise Value|Aclaris Therapeutics (ACRS) - Enterprise Value|kyvernatx.com (KYTX) - Total Company Value|Enterprise Value TLSA|Real Price to Acquire Entire Company Cabaletta Bio Inc.|Ventyx Bio - Enterprise Value|Total Enterprise Value THTX (Theratechnologies, Inc)|Total Company Value Avalo Therapeutics, Inc AVTX|eledon.com - Total Company Value|AGEN - Total Company Value|CLYM - Total Company Value|Enterprise Value ZURA|ATYR (aTyr Pharmaceuticals) - Total Enterprise Value|ADAG - Total Company Value|Value Adjusted for Debt and Cash Ikena Oncology, Inc.|Enterprise Value STTK|Enterprise Value equilliumbio.com EQ|Real Price to Acquire Entire Company Connect Biopharma Holdings Limited|Value Adjusted for Debt and Cash Immunic Therapeutics IMUX|ATRA - Enterprise Value|IFRX - Total Company Value|X4 Pharmaceuticals, Inc. - Enterprise Value|ACET (Adicet Bio, Inc.) - Company Buyout Price|Total Company Value CELU (Celularity Inc)|Total Enterprise Value INMB|Total Company Value Barinthus Biotherapeutics (BRNS)|Total Company Value KZR (kezarlifesciences.com)|SABS: Total Company Value|Total Enterprise Value Akari Therapeutics PLC AKTX|Enterprise Value ENLV|QTTB - Full Takeover Company Value|GeoVax Labs, Inc. - Enterprise Value|edesabiotech.com (EDSA) - Company Buyout Price|Enterprise Value IBIO|Real Price to Acquire Entire Company CARM|XTLB (XTL Biopharmaceuticals, Ltd.) - Total Company Value|Company Buyout Price boltbio.com (BOLT)|Enterprise Value HCWB (HCW Biologics)|Enterprise Value Aptevo Therapeutics, Inc. APVO|AIM - Enterprise Value|ADTX - Total Company Value|GRI (GRI Bio Corp) - Enterprise Value|XRTX (XORTX Corp) - Real Price to Acquire Entire Company|Total Company Value Vyome Holdings Inc|Total Company Value REVB|INDP - Total Company Value|Full Business Value Scinai Immunotherapeutics Ltd (SCNI)|Enterprise Value CalciMedica|Value Adjusted for Debt and Cash Affimed NV AFMD|Allakos Therapeutics - Enterprise Value|HOOK: Enterprise Value|Total Company Value igmbio.com IGMS|ITOS (iTeos Therapeutics Inc) - Value Adjusted for Debt and Cash|Total Company Value OCEA|Real Price to Acquire Entire Company TC BioPharm Ltd|Enterprise Value THRD